Literature DB >> 3684381

Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals.

M C Rose1, C F Brown, J Z Jacoby, W S Lynn, B Kaufman.   

Abstract

Tracheobronchial mucins from healthy individuals and from patients with bronchial asthma or cystic fibrosis (CF) were isolated from lung mucus, purified, and their chemical and physical properties compared. Normal and asthmatic mucins required both a dissociating and a reducing agent for solubilization and exhibited identical chromatographic behavior on Sepharose 4B, Sepharose 2B, and hydroxylapatite and similar amino acid and carbohydrate compositions. In contrast, 1) CF lung mucins were solubilized in the absence of dissociating and/or reducing agents and 2) the majority of the CF mucins analyzed was eluted in the included volume of Sepharose 4B with Kd values of 0.3 +/- 0.1 rather than in the void volume and thus appeared smaller than normal and asthmatic mucins. The lower molecular weight mucins in CF sputum apparently are produced by bacterial or inflammatory cell proteinases since radiolabelled asthmatic mucin was digested to smaller fragments when incubated with crude CF lung mucosal samples. Furthermore, mucins secreted by tracheal explants from CF and from non-CF individuals eluted in the void volume on Sepharose 4B, suggesting that CF tracheobronchial mucins were not inherently smaller than non-CF mucins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3684381     DOI: 10.1203/00006450-198711000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.

Authors:  J R Davies; N Svitacheva; L Lannefors; R Kornfält; I Carlstedt
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 2.  Cystic fibrosis: an inherited disease affecting mucin-producing organs.

Authors:  Camille Ehre; Caroline Ridley; David J Thornton
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

3.  Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.

Authors:  J W Nelson; M W Tredgett; J K Sheehan; D J Thornton; D Notman; J R Govan
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.

Authors:  D J Thornton; J K Sheehan; H Lindgren; I Carlstedt
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

5.  IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone.

Authors:  Yajun Chen; Lindsay M Garvin; Tracey J Nickola; Alan M Watson; Anamaris M Colberg-Poley; Mary C Rose
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-31       Impact factor: 5.464

6.  Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching.

Authors:  Nico Derichs; Byung-Ju Jin; Yuanlin Song; Walter E Finkbeiner; A S Verkman
Journal:  FASEB J       Date:  2011-03-22       Impact factor: 5.191

7.  A morphometric study of mucins and small airway plugging in cystic fibrosis.

Authors:  Pierre-Régis Burgel; David Montani; Claire Danel; Daniel J Dusser; Jay A Nadel
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

8.  Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.

Authors:  Oxana Norkina; Tim G Burnett; Robert C De Lisle
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Mucin-like glycoprotein secreted by cultured hamster tracheal epithelial cells. Biochemical and immunological characterization.

Authors:  R Wu; C G Plopper; P W Cheng
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

10.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.